Cross reactivity of immune responses to porcine reproductive and respiratory syndrome virus infection

Vaccine

Volumn 35, Issue 5, 2017, Pages 782-788

  Correas, Ignacio ^a   Osorio, Fernando A ^a   Steffen, David ^a   Pattnaik, Asit K ^a   Vu, Hiep L X ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Cell mediated immunity; Heterologous immunity; Interferon ; Porcine reproductive and respiratory syndrome virus (PRRSV); T cell cross reactivity

Indexed keywords

ANTIGEN; GAMMA INTERFERON; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTERIVIRUS INFECTION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; EXPERIMENTAL PIG; GENETIC DISTANCE; NONHUMAN; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS ISOLATION; ANIMAL; BIOSYNTHESIS; CLASSIFICATION; GENETIC VARIATION; GENETICS; GENOTYPE; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; PIG; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; VIROLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CROSS REACTIONS; GENETIC VARIATION; GENOTYPE; IMMUNITY, CELLULAR; INTERFERON-GAMMA; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SWINE; T-LYMPHOCYTES;

EID: 85008474035     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.12.040     Document Type: Article

References (49)

1. [1] Collins, J.E., Benfield, D.A., Christianson, W.T., Harris, L., Hennings, J.C., Shaw, D.P., et al. Isolation of swine infertility and respiratory syndrome virus (isolate ATCC VR-2332) in North America and experimental reproduction of the disease in gnotobiotic pigs. J Vet Diagn Invest 4 (1992), 117–126.
2. [2] Wensvoort, G., Terpstra, C., Pol, J.M., ter Laak, E.A., Bloemraad, M., de Kluyver, E.P., et al. Mystery swine disease in The Netherlands: the isolation of Lelystad virus. Vet Quart 13 (1991), 121–130.
3. [3] Holtkamp, D.J., Kliebenstein, J.B., Neumann, E.J., Zimmerman, J.J., Rotto, H.F., Yoder, T.K., et al. Assessment of the economic impact of porcine reproductive and respiratory syndrome virus on United States pork producers. J Swine Health Prod 21 (2013), 72–84.
4. [4] Cavanagh, D., Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Arch Virol 142 (1997), 629–633.
5. [5] Nelsen, C.J., Murtaugh, M.P., Faaberg, K.S., Porcine reproductive and respiratory syndrome virus comparison: divergent evolution on two continents. J Virol 73 (1999), 270–280.
6. [6] Allende, R., Lewis, T.L., Lu, Z., Rock, D.L., Kutish, G.F., Ali, A., et al. North American and European porcine reproductive and respiratory syndrome viruses differ in non-structural protein coding regions. J Gen Virol 80:Pt 2 (1999), 307–315.
7. [7] Allende, R., Laegreid, W.W., Kutish, G.F., Galeota, J.A., Wills, R.W., Osorio, F.A., Porcine reproductive and respiratory syndrome virus: description of persistence in individual pigs upon experimental infection. J Virol 74 (2000), 10834–10837.
8. [8] Loving, C.L., Osorio, F.A., Murtaugh, M.P., Zuckermann, F.A., Innate and adaptive immunity against porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol 167 (2015), 1–14.
9. [9] Yoon, I.J., Joo, H.S., Goyal, S.M., Molitor, T.W., A modified serum neutralization test for the detection of antibody to porcine reproductive and respiratory syndrome virus in swine sera. J Vet Diagn Invest 6 (1994), 289–292.
10. [10] Meier, W., Wheeler, J., Husmann, R.J., Osorio, F., Zuckermann, F.A., Characteristics of the immune response of pigs to PRRS virus. Vet Res, 31, 2000, 41.
11. [11] Meier, W.A., Galeota, J., Osorio, F.A., Husmann, R.J., Schnitzlein, W.M., Zuckermann, F.A., Gradual development of the interferon-gamma response of swine to porcine reproductive and respiratory syndrome virus infection or vaccination. Virology 309 (2003), 18–31.
12. [12] Vu, H.L., Kwon, B., Yoon, K.J., Laegreid, W.W., Pattnaik, A.K., Osorio, F.A., Immune evasion of porcine reproductive and respiratory syndrome virus through glycan shielding involves both glycoprotein 5 as well as glycoprotein 3. J Virol 85 (2011), 5555–5564.
13. [13] Osorio, F.A., Galeota, J.A., Nelson, E., Brodersen, B., Doster, A., Wills, R., et al. Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity. Virology 302 (2002), 9–20.
14. [14] Lopez, O.J., Oliveira, M.F., Garcia, E.A., Kwon, B.J., Doster, A., Osorio, F.A., Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent. Clin Vaccine Immunol 14 (2007), 269–275.
15. [15] Xiao, Z., Batista, L., Dee, S., Halbur, P., Murtaugh, M.P., The level of virus-specific T-cell and macrophage recruitment in porcine reproductive and respiratory syndrome virus infection in pigs is independent of virus load. J Virol 78 (2004), 5923–5933.
16. [16] Lowe, J.E., Husmann, R., Firkins, L.D., Zuckermann, F.A., Goldberg, T.L., Correlation of cell-mediated immunity against porcine reproductive and respiratory syndrome virus with protection against reproductive failure in sows during outbreaks of porcine reproductive and respiratory syndrome in commercial herds. J Am Vet Med Assoc 226 (2005), 1707–1711.
17. [17] Meier, W.A., Husmann, R.J., Schnitzlein, W.M., Osorio, F.A., Lunney, J.K., Zuckermann, F.A., Cytokines and synthetic double-stranded RNA augment the T helper 1 immune response of swine to porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol 102 (2004), 299–314.
18. [18] Charerntantanakul, W., Platt, R., Johnson, W., Roof, M., Vaughn, E., Roth, J.A., Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol 109 (2006), 99–115.
19. [19] Zuckermann, F.A., Garcia, E.A., Luque, I.D., Christopher-Hennings, J., Doster, A., Brito, M., et al. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge. Vet Microbiol 123 (2007), 69–85.
20. [20] Murtaugh, M.P., Stadejek, T., Abrahante, J.E., Lam, T.T., Leung, F.C., The ever-expanding diversity of porcine reproductive and respiratory syndrome virus. Virus Res 154 (2010), 18–30.
21. [21] Meng, X.J., Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development. Vet Microbiol 74 (2000), 309–329.
22. [22] Nelson, E.A., Christopher-Hennings, J., Drew, T., Wensvoort, G., Collins, J.E., Benfield, D.A., Differentiation of U.S. and European isolates of porcine reproductive and respiratory syndrome virus by monoclonal antibodies. J Clin Microbiol 31 (1993), 3184–3189.
23. [23] Truong, H.M., Lu, Z., Kutish, G.F., Galeota, J., Osorio, F.A., Pattnaik, A.K., A highly pathogenic porcine reproductive and respiratory syndrome virus generated from an infectious cDNA clone retains the in vivo virulence and transmissibility properties of the parental virus. Virology 325 (2004), 308–319.
24. [24] Wang, Y., Liang, Y., Han, J., Burkhart, K.M., Vaughn, E.M., Roof, M.B., et al. Attenuation of porcine reproductive and respiratory syndrome virus strain MN184 using chimeric construction with vaccine sequence. Virology 371 (2008), 418–429.
25. [25] Fang, Y., Rowland, R.R., Roof, M., Lunney, J.K., Christopher-Hennings, J., Nelson, E.A., A full-length cDNA infectious clone of North American type 1 porcine reproductive and respiratory syndrome virus: expression of green fluorescent protein in the Nsp2 region. J Virol 80 (2006), 11447–11455.
26. [26] Edgar, R.C., MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucl Acids Res 32 (2004), 1792–1797.
27. [27] Parida, R., Choi, I.S., Peterson, D.A., Pattnaik, A.K., Laegreid, W., Zuckermann, F.A., et al. Location of T-cell epitopes in nonstructural proteins 9 and 10 of type-II porcine reproductive and respiratory syndrome virus. Virus Res 169 (2012), 13–21.
28. [28] Nelson, E.A., Christopher-Hennings, J., Benfield, D.A., Serum immune responses to the proteins of porcine reproductive and respiratory syndrome (PRRS) virus. J Vet Diagn Invest 6 (1994), 410–415.
29. [29] Wu, W.H., Fang, Y., Farwell, R., Steffen-Bien, M., Rowland, R.R., Christopher-Hennings, J., et al. A 10-kDa structural protein of porcine reproductive and respiratory syndrome virus encoded by ORF2b. Virology 287 (2001), 183–191.
30. [30] Renukaradhya, G.J., Meng, X.J., Calvert, J.G., Roof, M., Lager, K.M., Live porcine reproductive and respiratory syndrome virus vaccines: current status and future direction. Vaccine 33 (2015), 4069–4080.
31. [31] Shi, M., Lam, T.T., Hon, C.C., Hui, R.K., Faaberg, K.S., Wennblom, T., et al. Molecular epidemiology of PRRSV: a phylogenetic perspective. Virus Res 154 (2010), 7–17.
32. [32] Vu, H.L., Ma, F., Laegreid, W.W., Pattnaik, A.K., Steffen, D., Doster, A.R., et al. A synthetic porcine reproductive and respiratory syndrome virus strain confers unprecedented levels of heterologous protection. J Virol 89 (2015), 12070–12083.
33. [33] Klinge, K.L., Vaughn, E.M., Roof, M.B., Bautista, E.M., Murtaugh, M.P., Age-dependent resistance to porcine reproductive and respiratory syndrome virus replication in swine. Virol J, 6, 2009, 177.
34. [34] McMaster, S.R., Gabbard, J.D., Koutsonanos, D.G., Compans, R.W., Tripp, R.A., Tompkins, S.M., et al. Memory T cells generated by prior exposure to influenza cross react with the novel H7N9 influenza virus and confer protective heterosubtypic immunity. PLoS One, 10, 2015, e0115725.
35. [35] Sewell, A.K., Why must T cells be cross-reactive?. Nat Rev Immunol 12 (2012), 669–677.
36. [36] Diaz, I., Gimeno, M., Darwich, L., Navarro, N., Kuzemtseva, L., Lopez, S., et al. Characterization of homologous and heterologous adaptive immune responses in porcine reproductive and respiratory syndrome virus infection. Vet Res, 43, 2012, 30.
37. [37] Lopez, O.J., Osorio, F.A., Role of neutralizing antibodies in PRRSV protective immunity. Vet Immunol Immunopathol 102 (2004), 155–163.
38. [38] Martinez-Lobo, F.J., Diez-Fuertes, F., Simarro, I., Castro, J.M., Prieto, C., Porcine reproductive and respiratory syndrome virus isolates differ in their susceptibility to neutralization. Vaccine 29 (2011), 6928–6940.
39. [39] Franzoni, G., Kurkure, N.V., Edgar, D.S., Everett, H.E., Gerner, W., Bodman-Smith, K.B., et al. Assessment of the phenotype and functionality of porcine CD8 T cell responses following vaccination with live attenuated classical swine fever virus (CSFV) and virulent CSFV challenge. Clin Vaccine Immunol 20 (2013), 1604–1616.
40. [40] Franzoni, G., Kurkure, N.V., Essler, S.E., Pedrera, M., Everett, H.E., Bodman-Smith, K.B., et al. Proteome-wide screening reveals immunodominance in the CD8 T cell response against classical swine fever virus with antigen-specificity dependent on MHC class I haplotype expression. PLoS One, 8, 2013, e84246.
41. [41] Talker, S.C., Koinig, H.C., Stadler, M., Graage, R., Klingler, E., Ladinig, A., et al. Magnitude and kinetics of multifunctional CD4+ and CD8beta+ T cells in pigs infected with swine influenza A virus. Vet Res, 46, 2015, 52.
42. [42] Talker, S.C., Stadler, M., Koinig, H.C., Mair, K.H., Rodriguez-Gomez, I.M., Graage, R., et al. Influenza A virus infection in pigs attracts multifunctional and cross-reactive T cells to the lung. J Virol 90 (2016), 9364–9382.
43. [43] Gerner, W., Talker, S.C., Koinig, H.C., Sedlak, C., Mair, K.H., Saalmuller, A., Phenotypic and functional differentiation of porcine alphabeta T cells: current knowledge and available tools. Mol Immunol 66 (2015), 3–13.
44. [44] Patch, J.R., Pedersen, L.E., Toka, F.N., Moraes, M., Grubman, M.J., Nielsen, M., et al. Induction of foot-and-mouth disease virus-specific cytotoxic T cell killing by vaccination. Clin Vaccine Immunol 18 (2011), 280–288.
45. [45] De Silva, N.S., Klein, U., Dynamics of B cells in germinal centres. Nat Rev Immunol 15 (2015), 137–148.
46. [46] Kurosaki, T., Kometani, K., Ise, W., Memory B cells. Nat Rev Immunol 15 (2015), 149–159.
47. [47] Jacobson, R.M., Ovsyannikova, I.G., Vierkant, R.A., Pankratz, V.S., Poland, G.A., Independence of measles-specific humoral and cellular immune responses to vaccination. Hum Immunol 73 (2012), 474–479.
48. [48] Dhiman, N., Ovsyannikova, I.G., Ryan, J.E., Jacobson, R.M., Vierkant, R.A., Pankratz, V.S., et al. Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination. Clin Exp Immunol 142 (2005), 498–504.
49. [49] Sridhar, S., Heterosubtypic T-cell immunity to influenza in humans: challenges for universal T-cell influenza vaccines. Front Immunol, 7, 2016, 195.